Taro Pharm Inds (TARO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 03-2014 | 03-2013 | 03-2012 | 12-2011 | 03-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 360,859 | N/A | N/A | N/A | 25,950 |
| Depreciation Amortization | 16,567 | N/A | N/A | N/A | 4,700 |
| Income taxes - deferred | -23,708 | N/A | N/A | N/A | N/A |
| Accounts receivable | -21,312 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 1,804 | N/A | N/A | N/A | N/A |
| Other Working Capital | 10,430 | N/A | N/A | N/A | -5,950 |
| Other Operating Activity | 13,004 | 0 | 0 | 0 | -350 |
| Operating Cash Flow | $357,644 | $N/A | $N/A | $N/A | $24,350 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -113,545 | N/A | N/A | N/A | N/A |
| PPE Investments | -21,241 | N/A | N/A | N/A | -880 |
| Purchase Of Investment | -33,956 | N/A | N/A | N/A | N/A |
| Purchase Sale Intangibles | -4,555 | N/A | N/A | N/A | N/A |
| Other Investing Activity | -4,555 | 0 | 0 | 0 | -10,110 |
| Investing Cash Flow | $-173,297 | $N/A | $N/A | $N/A | $-10,990 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -11,874 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 1,262 | N/A | N/A | N/A | N/A |
| Common Stock Repurchased | -192,999 | N/A | N/A | N/A | N/A |
| Other Financing Activity | 149 | 0 | 0 | 0 | 10,990 |
| Financing Cash Flow | $-203,462 | $N/A | $N/A | $N/A | $10,990 |
| Exchange Rate Effect | -8,202 | N/A | N/A | N/A | 370 |
| Beginning Cash Position | 237,284 | N/A | N/A | N/A | 54,140 |
| End Cash Position | 209,967 | N/A | N/A | N/A | 78,870 |
| Net Cash Flow | $-27,317 | $N/A | $N/A | $N/A | $24,720 |
| Free Cash Flow | |||||
| Operating Cash Flow | 357,644 | N/A | N/A | N/A | 24,350 |
| Capital Expenditure | -21,249 | N/A | N/A | N/A | N/A |
| Free Cash Flow | 336,395 | 0 | 0 | 0 | 24,350 |